Korsana Biosciences, Inc. (KRSA)

NASDAQ: KRSA · Real-Time Price · USD

31.42

-0.58 (-1.81%)

Oct 1, 2026, 3:42 PM EDT - Market open

Korsana Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	7.75	4.51	0.32
Research & Development	44.16	32.79	0.34
Operating Expenses	51.91	37.29	0.65
Operating Income	-51.91	-37.29	-0.65
Interest & Investment Income	2.83	1.65	0.13
Pretax Income	-49.08	-35.64	-0.53
Net Income	-49.08	-35.64	-0.53
Net Income to Common	-49.08	-35.64	-0.53
Net Income Growth	-	-	-
Shares Outstanding (Basic)	4	3	2
Shares Outstanding (Diluted)	4	3	2
Shares Change	-	93.49%	-
EPS (Basic)	-13.37	-12.20	-0.35
EPS (Diluted)	-13.37	-12.20	-0.35
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
EBIT	-51.91	-37.29	-0.65